# The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2

> **NCT05647356** · NA · UNKNOWN · sponsor: **Royal College of Surgeons, Ireland** · enrollment: 16 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome
- Androgen Excess
- Metabolic Disease

## Interventions

- **DRUG:** Bicalutamide 50 mg

## Key facts

- **NCT ID:** NCT05647356
- **Lead sponsor:** Royal College of Surgeons, Ireland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2022-12-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05647356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05647356, "The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05647356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*